tiprankstipranks
Beam Therapeutics (BEAM)
NASDAQ:BEAM
US Market

Beam Therapeutics (BEAM) Income Statement

Compare
1,352 Followers

Beam Therapeutics Income Statement

Last quarter (Q3 2024), Beam Therapeutics's total revenue was $14.27M, a decrease of -17.01% from the same quarter last year. In Q3, Beam Therapeutics's net income was $-96.67M. See Beam Therapeutics’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 23Dec 22Dec 21Dec 20Dec 19
Total Revenue
$ 377.71M$ 60.92M$ 51.84M$ 24.00K$ 18.00K
Gross Profit
$ -59.67M$ 38.34M$ 35.40M$ -103.16M$ -5.39M
Operating Expenses
$ 554.19M$ 399.40M$ 444.31M$ 132.78M$ 75.17M
Depreciation and Amortization
$ 20.01M$ 22.58M$ 16.44M$ 9.47M$ 5.41M
EBITDA
$ -156.47M$ -324.33M$ -392.46M$ -128.03M$ -71.65M
Operating Income
$ -176.49M$ -338.48M$ -392.46M$ -132.76M$ -75.15M
Other Income/Expenses
$ 45.32M$ 78.30M$ 21.83M$ -61.83M$ -3.17M
Pretax Income
$ -131.16M$ -260.18M$ -370.64M$ -194.59M$ -78.33M
Net Income
$ -132.53M$ -263.59M$ -341.36M$ -256.42M$ -78.44M
Per Share Metrics
$ ―$ ―$ ―$ ―$ ―
Basic EPS
$ -1.72$ -3.76$ -5.31$ -5.49$ -1.53
Diluted EPS
$ -1.72$ -3.76$ -5.31$ -5.49$ -1.53
Weighted Average Shares Outstanding
77.15M 70.02M 64.23M 46.73M 51.34M
Weighted Average Shares Outstanding (Diluted)
77.15M 70.02M 64.23M 46.73M 51.34M
Currency in USD

Beam Therapeutics Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis